Cargando…

Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia

Statins are the first-line treatment for familial hypercholesterolemia (FH), but response is highly variable due to genetic and nongenetic factors. Here, we explored the association between response and genetic variability in 114 Brazilian adult FH patients. Specifically, a panel of 84 genes was ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dagli-Hernandez, Carolina, Borges, Jéssica Bassani, Marçal, Elisangela da Silva Rodrigues, de Freitas, Renata Caroline Costa, Mori, Augusto Akira, Gonçalves, Rodrigo Marques, Faludi, Andre Arpad, de Oliveira, Victor Fernandes, Ferreira, Glaucio Monteiro, Bastos, Gisele Medeiros, Zhou, Yitian, Lauschke, Volker M., Cerda, Alvaro, Hirata, Mario Hiroyuki, Hirata, Rosario Dominguez Crespo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144204/ https://www.ncbi.nlm.nih.gov/pubmed/35631530 http://dx.doi.org/10.3390/pharmaceutics14050944

Ejemplares similares

Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with Familial Hypercholesterolemia: a case report
por: Dagli-Hernandez, Carolina, et al.
Publicado: (2021)

Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
por: Cerda, Alvaro, et al.
Publicado: (2015)

Population-scale predictions of DPD and TPMT phenotypes using a quantitative pharmacogene-specific ensemble classifier
por: Zhou, Yitian, et al.
Publicado: (2020)

Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results
por: Zhou, Yitian, et al.
Publicado: (2022)

Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis
por: Radaelli, Graciane, et al.
Publicado: (2018)

Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary Flavonoids
por: Saito, Hiroki, et al.
Publicado: (2020)

The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
por: NODARI, SAVINA, et al.
Publicado: (2007)

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
por: Hamilton-Craig, Ian, et al.
Publicado: (2010)

The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia
por: Pang, Jing, et al.
Publicado: (2020)

The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma
por: Hussain, Azhar, et al.
Publicado: (2023)

Early efficacy and safety of statin therapy in Korean patients with hypercholesterolemia: Daegu and Gyeongbuk Statin Registry
por: Bae, Han Joon, et al.
Publicado: (2020)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
por: Laufs, Ulrich, et al.
Publicado: (2019)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
por: Mundal, Liv J., et al.
Publicado: (2022)

Inclisiran adjuvant therapy to statins for the use of hypercholesterolemia: a commentary
por: Vohra, Laiba Imran, et al.
Publicado: (2023)

Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins
por: Marco-Benedí, Victoria, et al.
Publicado: (2021)

Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial
por: Cardoso, Thiago Augusto Azevedo Maranhão, et al.
Publicado: (2021)

Real-World Data to Identify Hypercholesterolemia Patients on Suboptimal Statin Therapy
por: Kajinami, Kouji, et al.
Publicado: (2019)

When Do Paediatric Patients with Familial Hypercholesterolemia Need Statin Therapy?(*)
por: Hennig, Matylda, et al.
Publicado: (2017)

Lower‐Intensity Statins Contributing to Gaps in Care for Patients With Primary Severe Hypercholesterolemia
por: Eid, Wael E., et al.
Publicado: (2021)

Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke
por: Vuorio, Alpo, et al.
Publicado: (2021)

Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
por: Chan, Melody Lok-Yi, et al.
Publicado: (2022)

ABCC9 Is Downregulated and Prone to Microsatellite Instability on ABCC9tetra in Canine Breast Cancer
por: Hao, Pan, et al.
Publicado: (2022)

Pharmacogenomic network analysis of the gene-drug interaction landscape underlying drug disposition
por: Zhou, Yitian, et al.
Publicado: (2019)

Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health
por: Zhou, Yitian, et al.
Publicado: (2021)

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data
por: Zhou, Yitian, et al.
Publicado: (2022)

A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study
por: Welty, Francine K., et al.
Publicado: (2016)

Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
por: Braamskamp, Marjet J. A. M., et al.
Publicado: (2015)

Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment
por: Omer, Linda, et al.
Publicado: (2020)

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia
por: Agarwala, Anandita, et al.
Publicado: (2021)

Analysis of Insulin Resistance Among Children and Adolescents in Slovenia With Hypercholesterolemia After Treatment With Statins
por: Groselj, Urh, et al.
Publicado: (2022)

Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature
por: Yu, Min, et al.
Publicado: (2020)

Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
por: Cerda, Alvaro, et al.
Publicado: (2011)

Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines
por: Low, Floren G., et al.
Publicado: (2020)

Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone?
por: Medeiros, A. M., et al.
Publicado: (2023)

Can Non-Pharmacological Treatment Promote Additional Benefit for Children with Familial Hypercholesterolemia Treated with Statins?
por: Antoniazzi, Luiza
Publicado: (2018)

Features of Serum Fatty Acids at Acute Ischemic Stroke Onset in Statin-Treated Patients with Hypercholesterolemia
por: Mori, Takahisa, et al.
Publicado: (2020)

May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
por: Scicali, Roberto, et al.
Publicado: (2020)

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis
por: Jones, Laney K., et al.
Publicado: (2021)

Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues
por: Langslet, Gisle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lfno8d7kshcic5gv526h8b5j8o